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Possibly the combustion products of coal gas and natural gas differ in some relevant way. We could not separate the effects of the two types of gas because most of the study areas underwent a changeover from town to natural gas during 1973, and the children were exposed to the products of combustion of both gases.
The relation between gas cooking and respiratory disease seems to be stronger and more consistent for girls than for boys, as would be expected if girls spent more time in the family kitchen. If this is the case, and the difference between the sexes is purely the result of differing exposure, it seems likely that increased ventilation might be sufficient to dispel any risk.
Nevertheless, detailed research is required to determine whether the relation we have found is really due to a direct effect of the products of gas combustion on the respiratory tract before more complicated measures for the protection of health are considered.
Summary
The Ames Dextrostix-Eyetone system was evaluated for monitoring the blood glucose concentration during insulin-induced hypoglycaemia. The results agreed well with laboratory values for plasma glucose, obtained by an orthotoluidine method, and the method was practicable as a bedside technique. In two cases quick results obtained with the Eyetone enabled the insulin tolerance test to be interrupted to prevent severe hypoglycaemia before the clinical indications were obvious. The extra time and effort required were minimal, and its value
Introduction
The best validated test of pituitary growth hormone (GH) release in man is the insulin tolerance test (ITT), which allows GH and ACTH production by the pituitary to be assessed simultaneously. ' The test is especially useful as thyrotrophinreleasing hormone (TRH) and gonadotrophin-releasing hormone (GRH) may be given at the same time so that prolactin and gonadotrophin secretion can be assessed simultaneously.
Adequate hypoglycaemia must be achieved before the ITT can be considered to be satisfactorily completed. Hypoglycaemia is generally recognised from the clinical signs (such as sweating) and, retrospectively, by seeing that the plasma glucose concentration has fallen by at least 500O from the fasting value and is below 2-8 mmol/l (50 mg/100 ml) at the nadir. The whole study took seven months, during which time the same Eyetone instrument and the same laboratory techniques were used.
Results
The correlation between Dextrostix-Eyetone and laboratory glucose values in all 133 samples is shown in the figure. The correlation coefficient was 0 96 and the regression equation was: laboratory (mmol/l)=0 19+0 -96 Dextrostix-Eyetone (mmol/l). The standard error for the regression coefficient was 0-02 and that for the intercept was 0-07. The regression coefficient was highly significantly different from zero (P<0 001), though not from 1-0, whereas the intercept was significantly different from zero (P<0 05). The standard error of estimate of a single laboratory value from a single Eyetone value was 0 32 mmol/l (5 7 mg/100 ml) at values around the mean and, at the extremes, 0 33 mmol/l (5 9 mg/100 ml). There was no trend in the degree of correlation, although the correlation at 60 minutes (0-89) was significantly lower (P < 0 05) than that at 15 minutes (0 97), which was the highest obtained. The 60-minute group included the sample in which the greatest discordance was found (see below). The degree of correlation was independent of the mean glucose concentration.
The importance of familiarity with the instrument was also tested.
Comparing the first 69 samples with the second 64 (a purely arbitary division between the 12th and the 13th patients) the residual variance fell from 59 7 to 19 8 (mmol/1)2, which is highly significant (P < 0 001). No "acclimatisation" period was allowed for before the start of the study, so that this particular aspect could be investigated. Two investigations were interrupted by intravenous injections of 25 % glucose. On both occasions this was because of very low values of blood glucose as determined by the Dextrostix-Eyetone system on the 15-minute sample (0 60 and 0 67 mmol/l (11 and 12 mg/l00 ml)) followed five minutes later by a lower or substantially unchanged value (0-56 and 0 78 mmol/l (10 and 14 mg/100 ml) 100 ml) and the laboratory value was only 1 28 (23 mg/100 ml). There was no obvious reason for this discrepancy, and this extreme difference may have been due to an unknown external factor. This point lay more than six standard deviations from the regression line, when this was calculated after excluding the outlier, and it certainly seems not to reflect the usual relation between laboratory and Dextrostix-Eyetone values. It has, however, been included in all calculations, except as noted in the table.
Mean glucose values and correlation coefficients for Dextrostix-Eyetone and laboratory determinations at each sampling time. Finally, deteriorated Dextrostix were used intentionally in one patient who was excluded from the numerical analysis. The deterioration was judged by the colour of the reagent area of the strip being substantially darker than the zero point of the bottle colour chart. The results were extremely discordant, with a bias towards overestimating the blood glucose concentration. This confirms the need for assessing the condition of the Dextrostix before use, as indicated in the manufacturer's instructions.
Discussion
When blood sampling is being performed at 15-minute intervals or longer, the one and a half to two minutes needed to perform the Dextrostix-Eyetone measurements is easily absorbed. On several occasions it was perfectly possible to perform ITTs on two patients simultaneously. It is, however, better to have the instrument actually at the bedside, rather than in a side room, so that the patient need never be left. In most paediatric wards it is not convenient to keep the instrument in this way, so the Eyetone will probably be switched on and off between investigations. It is therefore important that the machine is given at least 30 minutes to stabilise after first being switched on. Preferably the instrument should be left on continuously, as this does not shorten its working life and achieves maximum stability.
There was a consistent difference between the plasma glucose values and the whole-blood glucose values, with a positive intercept of 019 mmol/I (3 4 mg/100 ml). This indicates that the plasma values from the laboratory were consistently slightly higher than the whole-blood values, as expected. Apart from this, and in common with other recent studies, '8 10 11 the Dextrostix-Eyetone and laboratory measurements agreed well. Only one sample gave misleading results, and this was not in a critical region of blood glucose values. We have considered lower blood glucose concentrations in more detail than other workers, and our findings have also shown that the DextrostixEyetone method is practical for bedside use and provides a reliable guide to events.
In two cases an ITT which might otherwise have resulted in prolonged, severe hypoglycaemia was interrupted, and correctly so, as judged by the subsequent laboratory-determined plasma glucose concentrations. In these two cases hypoglycaemia was reversed before the patient showed severe symptoms; this must have reduced substantially any risk to the patient. It has long been recommended, when performing an ITT, that if the patient is thought to be ACTH deficient as well as GH deficient, a smaller dose of insulin should be given (usually 0 05 IU/kg). This is sound advice, but in our study there was no reason to believe that either of the two patients who became severely hypoglycaemic were in this category, and all our patients were given a dose of 0 1 IU/kg. Indeed, the result of the test in both cases showed normal cortisol production, although both patients had isolated GH deficiency. They would therefore have normally been given the full dose of insulin, as indeed they were. The Dextrostix-Eyetone system therefore provided extra safety for these children.
The method also helped in a complementary manner. General experience with the ITT has shown that some patients fail to achieve adequate hypoglycaemia (probably when they have normal pituitary function), and the result is therefore equivocal. One such case occurred in this study; a second dose of insulin (0-05 IU/kg) was given at 30 minutes and the blood glucose concentration (Dextrostix-Eyetone) subsequently fell to 1-22 mmol/l (22 mgi100 ml) (the laboratory value was 1 44 mmol1l (26 mgi100 ml)). A normal growth hormone response was seen. This would probably not have occurred without the second dose of insulin, at which time the blood glucose concentration was 3 05 mmol/l by the DextrostixEyetone method and 2 83 mmol/l by the laboratory method (55 and 51 mg/100 ml respectively). This patient was thus saved the inconvenience of a repeat investigation at a later date.
In conclusion, we think that the Dextrostix-Eyetone system has a useful part to play in the performance of ITTs both by assuring the safety of the patient and by ensuring that a valid investigation is completed. We would, however, emphasise that the user must be experienced in using the system before maximum precision is obtained.
